Profile data is unavailable for this security.
About the company
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
- Revenue in DKK (TTM)401.54m
- Net income in DKK143.80m
- Incorporated1997
- Employees171.00
- LocationChemometec A/SGydevang 43ALLEROED 3450DenmarkDNK
- Websitehttps://chemometec.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi Xinje Electric Co Ltd | 1.46bn | 194.59m | 4.44bn | 2.20k | 22.82 | 2.15 | -- | 3.05 | 1.44 | 1.44 | 10.79 | 15.32 | 0.5186 | 1.66 | 9.83 | 688,861.20 | 6.93 | 11.27 | 9.60 | 14.94 | 36.75 | 37.15 | 13.36 | 20.59 | 2.03 | -- | 0.1468 | 12.68 | 12.73 | 20.58 | -10.37 | 6.01 | 36.26 | 7.96 |
Siglent Technologies Co Ltd | 465.84m | 143.88m | 4.75bn | 462.00 | 32.87 | 3.10 | -- | 10.20 | 0.9449 | 0.9449 | 3.06 | 10.01 | 0.2902 | 0.9396 | 6.33 | 1,049,530.00 | 8.96 | 10.79 | 9.47 | 11.64 | 61.56 | 57.69 | 30.89 | 29.23 | 14.52 | -- | 0.023 | 60.22 | 21.50 | 25.68 | 10.29 | 39.96 | 75.52 | -- |
ChemoMetec A/S | 401.54m | 143.80m | 5.49bn | 171.00 | 38.15 | 11.00 | 33.82 | 13.66 | 8.26 | 8.26 | 23.07 | 28.66 | 0.6982 | 0.8064 | 6.01 | 2,448,421.00 | 25.00 | 30.43 | 29.69 | 38.99 | 78.85 | 79.44 | 35.81 | 34.17 | 3.37 | -- | 0.0118 | 46.90 | 3.74 | 31.58 | 12.04 | 57.88 | 19.91 | -- |
Standard Biotools Inc | 883.63m | -947.92m | 5.54bn | 534.00 | -- | 1.42 | -- | 6.27 | -0.9957 | -0.9957 | 0.9537 | 1.52 | 0.2206 | 2.05 | 5.02 | 237,380.20 | -15.66 | -28.17 | -18.29 | -33.60 | 49.15 | 51.58 | -70.98 | -74.85 | 4.17 | -- | 0.0869 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
Suzhou Veichi Electric Co Ltd | 1.30bn | 193.71m | 5.80bn | 1.42k | 27.58 | 3.04 | -- | 4.48 | 1.04 | 1.04 | 6.85 | 9.44 | 0.6302 | 2.91 | 2.99 | 948,722.10 | 9.36 | 10.41 | 13.07 | 14.75 | 37.83 | 36.16 | 14.85 | 14.78 | 1.75 | -- | 0.082 | 26.14 | 44.03 | 29.60 | 36.40 | 40.16 | 58.99 | -- |
Judges Scientific PLC | 1.20bn | 84.01m | 5.96bn | 714.00 | 73.58 | 8.15 | 26.64 | 4.95 | 1.38 | 1.38 | 20.56 | 12.46 | 0.7371 | -- | 5.37 | 190,616.30 | 5.36 | 10.16 | 7.49 | 14.75 | -- | 65.72 | 7.27 | 11.15 | 1.11 | 5.19 | 0.4415 | 64.73 | 20.22 | 11.81 | -23.62 | 2.26 | 43.94 | 18.89 |
Guodian Nanjing Automation Co., Ltd. | 7.43bn | 231.16m | 6.05bn | 3.61k | 29.06 | 2.02 | -- | 0.815 | 0.256 | 0.256 | 8.28 | 3.68 | 0.8152 | 4.30 | 2.13 | 2,144,556.00 | 4.49 | 3.63 | 12.93 | 11.27 | 23.46 | 24.39 | 5.51 | 5.43 | 1.08 | 19.51 | 0.136 | 36.60 | 8.78 | 9.10 | 48.98 | 34.16 | 8.46 | 21.98 |
Suzhou TZTEK Technology Co Ltd | 1.59bn | 202.34m | 6.31bn | 2.05k | 32.06 | 3.51 | -- | 3.96 | 1.06 | 1.06 | 8.57 | 9.72 | 0.5176 | 1.00 | 3.62 | 811,397.70 | 6.57 | 6.03 | 9.91 | 8.47 | 40.82 | 41.01 | 12.69 | 11.52 | 0.9966 | -- | 0.2987 | 49.72 | 3.70 | 26.52 | 41.46 | 17.90 | 31.24 | -- |
SAM Engineering & Equipment (M) Bhd | 2.21bn | 160.38m | 6.50bn | 1.97k | 33.63 | 3.07 | 23.81 | 2.94 | 0.1933 | 0.1933 | 2.66 | 2.12 | 0.8149 | 2.87 | 2.32 | -- | 5.91 | 6.77 | 8.97 | 10.17 | 15.45 | 12.92 | 7.25 | 6.99 | 1.39 | 5.37 | 0.1814 | 21.75 | 3.60 | 14.68 | 22.21 | 6.70 | -1.25 | -5.09 |
Holder | Shares | % Held |
---|---|---|
BlackRock Investment Management (UK) Ltd.as of 13 Jun 2024 | 1.67m | 9.62% |
Invesco Advisers, Inc.as of 16 May 2023 | 881.14k | 5.06% |
Swedbank Robur Fonder ABas of 31 May 2024 | 754.00k | 4.33% |
Handelsbanken Fonder ABas of 31 May 2024 | 642.14k | 3.69% |
Fj�rde AP-fondenas of 31 Dec 2023 | 600.00k | 3.45% |
The Vanguard Group, Inc.as of 06 Jun 2024 | 572.45k | 3.29% |
SEB Investment Management AB (Denmark)as of 31 May 2024 | 561.92k | 3.23% |
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 28 Mar 2024 | 460.00k | 2.64% |
Fidelity Management & Research Co. LLCas of 30 Apr 2024 | 452.86k | 2.60% |
Norges Bank Investment Managementas of 31 Dec 2023 | 411.11k | 2.36% |